The NIDA’s research training and career development team invites undergraduates, recent graduates, and early career scholars to join a 5-part virtual series to learn about graduate programs to consider and high priority areas within substance use and addiction research. Sessions include: July 2, 2025: "Should I Apply to Graduate School." Come ready to learn from Christie Brannock as she discusses different types of graduate programs, how to find them, the application process/timeline, and receive expert tips/advice on this next stage in your academic journey. July 9, 2025: Dr. Tisha Wiley from NIDA's Division of Epidemiology, Services and Prevention Research (DESPR) will be presenting on "Improving Treatment and Recovery Services for Adolescents & Young Adults." This seminar will cover approaches to addressing addiction in adolescents and young adults, including increasing uptake of effective interventions such as Medications for Opioid Use Disorder (MOUDs), engaging family and loved ones, and long-term recovery. July 16, 2025: NIDA substance use disorders (SUD) researchers and career development professionals including Drs. Catalina Lopez-Quintero, Charles Parry, Silvia Cruz, and Jeffrey Samet will engage in a panel discussion on "Identifying and Collaborating with Research Mentors.” July 23, 2025: Dr. Tristan McClure-Begley from NIDA's Division of Neuroscience and Behavior (DNB) will provide an in-depth discussion on “Quantifying Internal States Relevant to Substance Use" which will introduce behavioral pharmacology approaches used to study the effects of psychoactive substances, examples of commonly used addictive and therapeutic drugs, and how new technology is changing how we measure drug effects. July 30, 2025: Dr. Lorenzo Leggio from NIDA’s IRP will provide a presentation on “Unlocking New Treatments for Addiction: A Scientific Journey Through the Gut-Brain Axis” which will explore emerging basic, translational, and clinical evidence supporting the role of gut-brain neuroendocrine pathways (e.g., glucagon-like peptide-1) in addictive disorders, highlighting these pathways as potential targets for the development of novel treatments. It is recommended that you join the webinars 5 minutes early to prevent any technical delays as this is a new webinar format being used by NIDA.

Follow our schedule to connect with CHERISH researchers and colleagues attending the 2025 Society for Epidemiologic Research Conference. View the full program online.

Follow the itinerary below to connect with CHERISH researchers and colleagues attending AcademyHealth's Annual Research Conference. View the full conference program on their website.

Connect with CHERISH Research Affiliates, Advisory Board members, and pilot grant recipients in person as they present their research at #ASHEcon2025.

The Society for Medical Decision Making (SMDM) North American Meeting brings together high-quality oral and poster presentations, short courses, symposia presentations, and workshops from all disciplines involved in the study of decision making in health and medicine. Connect with CHERISH researchers and colleagues attending this year and view the full program online.

Follow the itinerary below to connect with CHERISH researchers and colleagues attending #CPDD25 or view the full conference program on their website.

This free virtual workshop, open to all, includes a robust agenda that demonstrates how health economics research informs treatment and care for people with substance use disorder, mental health illnesses, and related conditions. Co-led by NIH HEAL Initiative, the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH), the half-day workshop and forum features multidisciplinary experts in health economics and health services research, including CHERISH investigators Yuhua Bao, Sean M. Murphy, and Bruce Schackman; CHERISH Research Affiliates Todd Olmstead, Erica Crable, Beth McGinty, and Catherine Maclean; and former pilot grant recipient Sierra Castedo De Martell. Researchers, advocacy organizations, health system and community treatment providers, federal partners, policymakers, individuals with lived or living experience with substance use disorder and serious mental illness, and others interested in supporting cost-effective and quality care are welcome to attend, connect with the panelists, and share research priorities to consider.